Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | XENE | Common Shares | Options Exercise | $65K | +3.5K | $18.56* | 3.5K | Mar 8, 2024 | Direct | ||
transaction | XENE | Common Shares | Tax liability | -$65K | -1.41K | -40.23% | $46.16 | 2.09K | Mar 8, 2024 | Direct | F1 |
transaction | XENE | Common Shares | Sale | -$95.6K | -2.09K | -100% | $45.69 | 0 | Mar 8, 2024 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | XENE | Stock Option (Right to Buy) | Options Exercise | $0 | -3.5K | -17.5% | $0.00 | 16.5K | Mar 8, 2024 | Common Shares | 20K | $18.56 | Direct | F2 |
Id | Content |
---|---|
F1 | Represents the closing price of the Company's common shares on March 7, 2024 for purposes of net settlement calculations. |
F2 | One-third of the total shares subject to the Option vested on the one year anniversary of the grant date, one-third of the total shares subject to the Option vested on the two year anniversary of the grant date, and one-third of the total shares subject to the Option shall vest on the three year anniversary of the grant date. |